BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yaprak O, Acar S, Ertugrul G, Dayangac M. Role of pre-transplant 18F-FDG PET/CT in predicting hepatocellular carcinoma recurrence after liver transplantation. World J Gastrointest Oncol 2018; 10(10): 336-343 [PMID: 30364796 DOI: 10.4251/wjgo.v10.i10.336]
URL: https://www.wjgnet.com/1948-5182/full/v10/i10/336.htm
Number Citing Articles
1
Seok‐Hwan Kim, Deok‐Bog Moon, Gil‐Chun Park, Sung‐Gyu Lee, Shin Hwang, Chul‐Soo Ahn, Ki‐Hun Kim, Tae‐Yong Ha, Gi‐Won Song, Dong‐Hwan Jung, Young‐In Yoon, Hwa‐Jung Kim. Preoperative prediction score of hepatocellular carcinoma recurrence in living donor liver transplantation: Validation of SNAPP score developed at Asan Medical CenterAmerican Journal of Transplantation 2021; 21(2): 604 doi: 10.1111/ajt.16227
2
Sirish A. Kishore, Michael J. Drabkin, Constantinos T. Sofocleous. Fluorodeoxyglucose-PET for Ablation Treatment Planning, Intraprocedural Monitoring, and ResponsePET Clinics 2019; 14(4): 427 doi: 10.1016/j.cpet.2019.06.006
3
Brandon A. Howard, Terence Z. Wong. 18F-FDG-PET/CT Imaging for Gastrointestinal MalignanciesRadiologic Clinics of North America 2021; 59(5): 737 doi: 10.1016/j.rcl.2021.06.001
4
Thomas Winkens, William Rudakoff, Falk Rauchfuss, Christina Malessa, Utz Settmacher, Martin Freesmeyer. FDG PET/CT to Detect Incidental Findings in Patients With Hepatocellular Carcinoma—Additional Benefit for Patients Considered for Liver Transplantation?Clinical Nuclear Medicine 2021; 46(7): 532 doi: 10.1097/RLU.0000000000003576
5
2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II RecommendationsJournal of Clinical and Experimental Hepatology 2020; 10(1): 43 doi: 10.1016/j.jceh.2019.09.007
6
Michele Finotti, Alessandro Vitale, Michael Volk, Umberto Cillo. A 2020 update on liver transplant for hepatocellular carcinomaExpert Review of Gastroenterology & Hepatology 2020; 14(10): 885 doi: 10.1080/17474124.2020.1791704
7
Edouard Reizine, Julia Chalaye, Sebastien Mule, Helene Regnault, Clara Perrin, Julien Calderaro, Alexis Laurent, Giuliana Amaddeo, Hicham Kobeiter, Vania Tacher, Emmanuel Itti, Alain Luciani. Utility of Early Posttreatment PET/CT Evaluation Using FDG or 18F-FCH to Predict Response to 90Y Radioembolization in Patients With Hepatocellular CarcinomaAmerican Journal of Roentgenology 2022; 218(2): 359 doi: 10.2214/AJR.21.26485
8
Silvio Nadalin, Lara Genedy, Alfred Königsrainer. Ethical Challenges in Cancer Diagnosis and TherapyRecent Results in Cancer Research 2021; 218: 135 doi: 10.1007/978-3-030-63749-1_10
9
Pierluigi Toniutto, Elisa Fumolo, Ezio Fornasiere, Davide Bitetto. Liver Transplantation in Patients with Hepatocellular Carcinoma beyond the Milan Criteria: A Comprehensive ReviewJournal of Clinical Medicine 2021; 10(17): 3932 doi: 10.3390/jcm10173932
10
Filiz Çelebi, Aysegül Görmez, Ahmet Serkan Ilgun, Yaman Tokat, Numan Cem Balcı. The value of 18F-FDG PET/MRI in prediction of microvascular invasion in hepatocellular carcinomaEuropean Journal of Radiology 2022; 149: 110196 doi: 10.1016/j.ejrad.2022.110196
11
Francesco Paolo Russo, Alberto Zanetto. Textbook of Liver Transplantation2022; : 389 doi: 10.1007/978-3-030-82930-8_22
12
Yi Wei, Zixing Huang, Hehan Tang, Liping Deng, Yuan Yuan, Jiaxing Li, Dongbo Wu, Xiaocheng Wei, Bin Song. IVIM improves preoperative assessment of microvascular invasion in HCCEuropean Radiology 2019; 29(10): 5403 doi: 10.1007/s00330-019-06088-w
13
Filiz Çelebi, Kourosh Yaghouti, Emetullah Cindil, Gülen Bülbül Dogusoy, Yaman Tokat, Cem Balcı. The Role of 18F-FDG PET/MRI in the Assessment of Primary Intrahepatic NeoplasmsAcademic Radiology 2021; 28(2): 189 doi: 10.1016/j.acra.2020.01.026